Incidental detection of hemoglobin abnormalities by HBA1C assay with high pressure liquid chromatography;Detection fortuite d'anomalies de l'hemoglobine lors du dosage de l'hemoglobine glyquee par une technique de chromatographie liquide haute pression

Annales de Biologie Clinique

Volumn 57, Issue 6, 1999, Pages 713-716

  Lemee V ^a   Hue, G ^a   Lahary, A ^a   Lavoinne, A ^a  

^a HÔPITAL CHARLES NICOLLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN D; HEMOGLOBIN F; HEMOGLOBIN VARIANT;

ARTICLE; CLINICAL ARTICLE; HEMOGLOBINOPATHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ADULT; BIOLOGICAL MODEL; BLOOD; COMPARATIVE STUDY; DIABETES MELLITUS; ELECTROPHORESIS; HEMOGLOBIN LEPORE;

ADULT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETES MELLITUS; ELECTROPHORESIS; FETAL HEMOGLOBIN; HEMOGLOBIN A, GLYCOSYLATED; HEMOGLOBINS, ABNORMAL; HUMANS; MODELS, BIOLOGICAL;

EID: 0032754267     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993 ; 977-86.
2. Collins AF, Dover GJ, Luban NL. Increased fetal hemoglobin production in patients receiving valproic acid for epilepsy. Blood 1994 ; 84 : 1690-1.
3. Olivieri NF, Rees DC, Ginder GD, et al. Treatment of thalassemia major with phenylbutyrate and hydroxyurea. Lancet 1997 ; 350 : 491-2.
4. DeSimone J, Heller P, Hall L, Zwiers D. 5-azacytidine stimulates fetal hemoglobin synthesis in anemic baboons. Prod Natl Acad Sci USA 1982 ; 79 : 4428-31.
5. Weykamp CW, Penders TJ, Muskiet FAJ, van der Slick W. Influence of hemoglobins variants and derivatives on glycohemoglobin determinations, as investigated by 102 laboratories using 16 differents methods. Clin Chem 1993 ; 39 : 1717-23.
6. Hémoglobines. Cahiers de formation Bioforma 1997 : 8.
7. Serjeant GR. Sickle cell disease. Oxford, UK : Oxford University Press, 1992; Vol. 1, 2nd ed.
8. Delattre J, Gillery P. Dosage de la fructosamine et son intérêt dans la surveillance du diabète sucré (commission « protéines glyquées »). Option /Bio 1993 ; 104.
9. Gillery P. Valeurs de référence des fructosamines plasmatiques chez des sujets sains. Option/Bio 1993 ; 89.
10. Pileire B, Moutet JP, Bangou J, Ragoucy-Sengler CM. Marqueurs de la glycation des protéines dans le dépistage du diabète. Ann Biol Clin 1988 ; 46 : 719-21.
11. Martina WV, Martjin EG, Van der Molen M, Schermer JG, Muskiet FAJ. ß-N-terminal glycohemoglobins in subjects with commons hemoglobinopathies : relation with fructosamine and mean erythrocyte age. Clin Chem 1993 ; 39 : 2259-65.